Sabra Health Care REIT Q3 2024 Earnings Report
Key Takeaways
Sabra Health Care REIT reported its Q3 2024 results, showing positive performance in skilled nursing and managed senior housing. The company updated its 2024 earnings guidance, reflecting an expected year-over-year earnings growth of more than 6%. Investments for the quarter and subsequent to quarter end totaled roughly $100 million. The company's investment pipeline has seen increased activity.
Net Income was $0.13 per diluted common share.
FFO was $0.34 per diluted common share.
Normalized FFO was $0.35 per diluted common share.
AFFO was $0.36 per diluted common share.
Sabra Health Care REIT
Sabra Health Care REIT
Sabra Health Care REIT Revenue by Segment
Forward Guidance
Sabra is updating its 2024 earnings guidance ranges as follows (attributable to common stockholders, per diluted common share):
Positive Outlook
- Guidance ranges assume year-over-year same store Cash NOI growth in the mid-to-high teens for the managed senior housing portfolio.
- Guidance also incorporates all announced investment and disposition activity, as well as announced activity under the at-the-market equity offering program.
- Guidance does not assume additional investment, disposition or capital transactions beyond those already disclosed.
- The foregoing guidance ranges reflect management’s view of current and future market conditions.
- Increased the midpoint of our guidance, which implies year-over-year earnings growth of more than 6% for the full year.”
Challenges Ahead
- Net Income: $0.48 - $0.49
- FFO: $1.35 - $1.36
- Normalized FFO: $1.39 - $1.40
- AFFO: $1.41 - $1.42
- Normalized AFFO: $1.43 - $1.44
Revenue & Expenses
Visualization of income flow from segment revenue to net income